Articles Tagged With: aspergillosis
-
12 Months of Itraconazole Is Superior to Six Months for Preventing Relapses of Chronic Pulmonary Aspergillosis
A randomized, controlled clinical trial from India found a significant reduction in relapses of chronic pulmonary aspergillosis in patients treated with itraconazole for 12 months compared to those treated for six months. There were more adverse events in the patients treated for 12 months.
-
Invasive Aspergillosis Is an Independent Predictor of Mortality in Mechanically Ventilated Patients with SARS-CoV-2 Infection
This multicenter cohort study found a high incidence of invasive aspergillosis in mechanically ventilated patients with SARS-CoV-2 pneumonia.
-
Diagnosis and Management of Invasive Aspergillosis in 2016
This updated guideline takes into account newer diagnostic methods and therapeutic agents and their use in the treatment of aspergillosis.
-
Treatment of Invasive Aspergillosis: Are Two Drugs Better Than One?
Although potential benefit may have been detected in a post hoc subset analysis, the addition of anidulafungin in the initial phase of primary treatment of suspected or documented invasive aspergillosis was not associated with a significant improvement in survival.
-
Combination Therapy for Invasive Aspergillosis in Patients with Hematologic Malignancies or Hematopoeitic Cell Transplants
In an evaluation of the primary endpoint, all-cause mortality at 6 weeks, there was no statistically significant difference between treatment with voriconazole alone or in combination with anidulafungin in patients with invasive aspergillosis and hematologic malignancies or hematopoietic stem cell transplants.